Compared to patients treated for diabetes with a non-GLP-1 medication, GLP-1 use was associated with 14% reduced risk of developing any substance use disorder
By modulating these pathways, GLP-1s can reduce cravings for both food and other substances, such as alcohol
If a compound does not fit inside a sensible recovery plan, it is not a solution
Recent research data has shown that the expression of lipid metabolism genes adiponectin (APN), Adipo R, AMPK, PPAR mRNA and protein is significantly increased after 48 hours of treatment with different concentrations of GLP-1 compared with the model group of adipose hepatocytes [108]
"Dosage," "reconstitution," and "blend dosing" are three distinct intents
Before considering any treatment, it is important to discuss the procedures, necessary precautions, and likely results with a doctor